Peptides: The Body's Signaling Molecules
Your body is a vast communication network, and peptides are among its most important messengers. A peptide is a chain of amino acids - the same building blocks that make up proteins - typically ranging from 2 to 50 amino acids in length. Your body naturally produces thousands of different peptides that serve as hormones, neurotransmitters, growth factors, and immune modulators. Every time your heart beats, your muscles contract, or your immune system fights an infection, peptides are involved in coordinating the response.
The distinction between peptides and proteins is primarily one of size and complexity. Proteins are longer chains (typically over 50 amino acids) that fold into complex three-dimensional structures. Peptides are shorter and simpler, but they are no less important biologically. Insulin, for example, is a peptide hormone with 51 amino acids that regulates blood sugar in every cell of your body. Oxytocin, the "bonding hormone," is a peptide with just 9 amino acids. Endorphins - your body's natural painkillers - are peptides.
Therapeutic peptides harness this natural signaling system. Rather than introducing foreign chemicals that override biological processes, peptide therapy uses molecules that communicate through pathways your body already recognizes. This is a fundamental reason why peptide therapies often have favorable side effect profiles - they speak the body's own molecular language.
How Peptides Bind to Receptors
The mechanism by which peptides exert their effects is receptor binding - often described using the "lock and key" analogy. Every cell in your body has thousands of receptors on its surface - protein structures that protrude from the cell membrane like locks waiting for the right key. When a peptide with the right shape and chemical properties encounters its matching receptor, it binds to that receptor and triggers a response inside the cell.
This binding is highly specific. A GLP-1 receptor agonist like semaglutide binds specifically to GLP-1 receptors - it does not activate insulin receptors, growth hormone receptors, or other unrelated receptor types. This specificity is what allows peptide therapies to target particular biological processes without broadly affecting unrelated systems. However, receptors for a given peptide may exist in multiple tissues, which is why a single peptide can have effects in several organs.
When a peptide binds to its receptor, it triggers a cascade of events inside the cell called signal transduction. The receptor changes shape, activating intracellular signaling proteins, which in turn activate other proteins, ultimately leading to a specific cellular response - such as gene expression changes, enzyme activation, or ion channel opening. A single peptide binding event can amplify into a substantial cellular response through this cascade, which is why even small amounts of peptides can have significant biological effects.
Major Peptide Signaling Pathways
Different therapeutic peptides work through distinct signaling pathways, each targeting specific biological functions. Understanding these pathways helps explain why different peptides are used for different conditions.
The incretin pathway is central to metabolic peptide therapy. When you eat, your gut releases incretin hormones - GLP-1 and GIP - that signal the pancreas to release insulin, signal the brain to reduce appetite, and slow gastric emptying. Semaglutide and tirzepatide mimic these natural incretins, producing the same effects but with longer duration. They bind to receptors in the pancreas, hypothalamus, and gut, coordinating a metabolic response that reduces blood sugar, suppresses hunger, and slows digestion.
The growth hormone axis involves the hypothalamus releasing growth hormone-releasing hormone (GHRH), which stimulates the pituitary to release growth hormone, which then stimulates the liver to produce IGF-1. Sermorelin mimics GHRH to stimulate this entire cascade naturally. The growth factor pathway is engaged by peptides like BPC-157, which upregulates expression of vascular endothelial growth factor (VEGF) and other growth factors that promote tissue repair and blood vessel formation. The melanocortin pathway, activated by PT-141, regulates sexual arousal, appetite, and pigmentation through MC4 and MC1 receptors in the brain and skin.
How Peptides Are Absorbed and Metabolized
The way a peptide is administered significantly affects how it works in the body. Subcutaneous injection is the most common route because it allows the peptide to enter the bloodstream gradually through the capillary network beneath the skin. This provides sustained absorption over hours, maintaining effective blood levels without the rapid spike and decline seen with intravenous delivery. Most therapeutic peptides - including semaglutide, sermorelin, and BPC-157 - are administered this way.
Oral administration is challenging for most peptides because the gastrointestinal tract is designed to break down proteins and peptides during digestion. Stomach acid and digestive enzymes (particularly pepsin and trypsin) rapidly degrade most peptides before they can be absorbed into the bloodstream. This is why oral peptide therapy is the exception rather than the rule. BPC-157 is a notable exception - its stability in the gastric environment makes oral delivery effective, particularly for gut-targeted applications. Oral semaglutide uses a special formulation with an absorption enhancer to protect the peptide and facilitate intestinal absorption.
Once in the bloodstream, peptides are metabolized by enzymes called peptidases, which break them down into individual amino acids. The half-life of a peptide - how long it remains active in the body - varies enormously. Naturally occurring GLP-1 has a half-life of just 2-3 minutes, while semaglutide (engineered with an albumin-binding fatty acid chain) has a half-life of approximately one week. These pharmacological modifications allow for less frequent dosing and more consistent therapeutic effects.
Peptides vs. Traditional Pharmaceuticals
Peptide therapies differ from traditional small-molecule drugs in several important ways. Small-molecule drugs (like aspirin, statins, or most oral medications) are simple chemical compounds that can penetrate cell membranes and often affect multiple molecular targets. They are easy to manufacture and administer orally but may have broader off-target effects. Peptides, by contrast, are larger biological molecules that act on specific cell-surface receptors, giving them greater target specificity but also making them more challenging to deliver.
The specificity of peptides is a significant advantage. Because each peptide binds to a defined receptor type, the biological effect is more predictable and targeted. This often translates to a more favorable side effect profile - the peptide does what it is designed to do without significantly affecting unrelated systems. However, this specificity also means that peptides typically address one pathway at a time, which is why combination protocols using multiple peptides are sometimes used.
Peptide therapy also differs in how the body processes these molecules. Because peptides are made of amino acids - the same building blocks your body uses naturally - they are ultimately broken down into harmless components. They do not accumulate in the liver or kidneys the way some small-molecule drugs can. This does not mean peptides are without risk, but their metabolic fate is generally straightforward compared to synthetic chemicals that may produce active or toxic metabolites.
Why Responses Vary Between Individuals
One of the most common questions patients ask is "why do some people respond better to peptide therapy than others?" The answer lies in the biological diversity that makes each person unique. Genetic variations in receptor structure can affect how strongly a peptide binds and how robustly the cell responds. Receptor density - the number of receptors on cell surfaces - varies between individuals and changes with age, affecting the magnitude of the peptide's signal.
Metabolic factors also play a role. The rate at which an individual's body produces peptidases (the enzymes that break down peptides) affects how long the peptide remains active. Body composition influences distribution - a peptide distributes differently in someone with high lean mass versus high body fat. Gut microbiome composition can affect the absorption of orally administered peptides. Even circadian rhythm timing can influence peptide efficacy, which is why growth hormone peptides are often administered at bedtime.
This variability is precisely why physician oversight and individualized dosing matter. A prescribing physician considers your age, weight, health status, lab values, medication interactions, and treatment goals when designing your protocol. Follow-up monitoring allows for dose adjustments based on your actual response rather than population averages. Peptide therapy is not a standardized, one-size-fits-all treatment - it is personalized medicine that requires clinical expertise to optimize.